4
Changes in Ownership
Gain Therapeutics, Inc. Filed Acc 0001493152-24-012340
Director bought 30,000 shares at $3.86 ($115,770)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Riley Jeffrey Scott Director | 2024-03-28 | Purchase | +30,000 | $3.86 | $115,770 | 30,000 | D: show line 1 in the form |
| Open-market purchases · 30,000 sh · avg $3.86 · $115,770 | |||||||
Loading xslF345X05/ownership.xml…